Previous Article | Next Article 
Journal of Virology, October 2003, p. 10394-10403, Vol. 77, No. 19
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.19.10394-10403.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
An Alphavirus Replicon Particle Chimera Derived from Venezuelan Equine Encephalitis and Sindbis Viruses Is a Potent Gene-Based Vaccine Delivery Vector
Silvia Perri,* Catherine E. Greer, Kent Thudium, Barbara Doe, Harold Legg, Hong Liu, Raul E. Romero, Zequn Tang, Qian Bin, Thomas W. Dubensky Jr., Michael Vajdy, Gillis R. Otten, and John M. Polo
Vaccine Research, Chiron Corporation, Emeryville, California 94608
Received 14 February 2003/
Accepted 2 July 2003
Alphavirus replicon particle-based vaccine vectors derived from Sindbis virus (SIN), Semliki Forest virus, and Venezuelan equine encephalitis virus (VEE) have been shown to induce robust antigen-specific cellular, humoral, and mucosal immune responses in many animal models of infectious disease and cancer. However, since little is known about the relative potencies among these different vectors, we compared the immunogenicity of replicon particle vectors derived from two very different parental alphaviruses, VEE and SIN, expressing a human immunodeficiency virus type 1 p55Gag antigen. Moreover, to explore the potential benefits of combining elements from different alphaviruses, we generated replicon particle chimeras of SIN and VEE. Two distinct strategies were used to produce particles with VEE-p55gag replicon RNA packaged within SIN envelope glycoproteins and SIN-p55gag replicon RNA within VEE envelope glycoproteins. Each replicon particle configuration induced Gag-specific CD8+ T-cell responses in murine models when administered alone or after priming with DNA. However, Gag-specific responses varied dramatically, with the strongest responses to this particular antigen correlating with the VEE replicon RNA, irrespective of the source of envelope glycoproteins. Comparing the replicons with respect to heterologous gene expression levels and sensitivity to alpha/beta interferon in cultured cells indicated that each might contribute to potency differences. This work shows that combining desirable elements from VEE and SIN into a replicon particle chimera may be a valuable approach toward the goal of developing vaccine vectors with optimal in vivo potency, ease of production, and safety.
* Corresponding author. Mailing address: Chiron Corporation, 4560 Horton St., MS 4.3, Emeryville, CA 94608. Phone: (510) 923-8144. Fax: (510) 923-2586. E-mail:
silvia_perri{at}chiron.com.
Journal of Virology, October 2003, p. 10394-10403, Vol. 77, No. 19
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.19.10394-10403.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Yin, J., Gardner, C. L., Burke, C. W., Ryman, K. D., Klimstra, W. B.
(2009). Similarities and Differences in Antagonism of Neuron Alpha/Beta Interferon Responses by Venezuelan Equine Encephalitis and Sindbis Alphaviruses. J. Virol.
83: 10036-10047
[Abstract]
[Full Text]
-
Morner, A., Douagi, I., Forsell, M. N. E., Sundling, C., Dosenovic, P., O'Dell, S., Dey, B., Kwong, P. D., Voss, G., Thorstensson, R., Mascola, J. R., Wyatt, R. T., Karlsson Hedestam, G. B.
(2009). Human Immunodeficiency Virus Type 1 Env Trimer Immunization of Macaques and Impact of Priming with Viral Vector or Stabilized Core Protein. J. Virol.
83: 540-551
[Abstract]
[Full Text]
-
Gardner, C. L., Burke, C. W., Tesfay, M. Z., Glass, P. J., Klimstra, W. B., Ryman, K. D.
(2008). Eastern and Venezuelan Equine Encephalitis Viruses Differ in Their Ability To Infect Dendritic Cells and Macrophages: Impact of Altered Cell Tropism on Pathogenesis. J. Virol.
82: 10634-10646
[Abstract]
[Full Text]
-
Lin, Y., Kwon, T., Polo, J., Zhu, Y.-F., Coates, S., Crawford, K., Dong, C., Wininger, M., Hall, J., Selby, M., Coit, D., Medina-Selby, A., McCoin, C., Ng, P., Drane, D., Chien, D., Han, J., Vajdy, M., Houghton, M.
(2008). Induction of Broad CD4+ and CD8+ T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5 . J. Virol.
82: 7492-7503
[Abstract]
[Full Text]
-
Ljungberg, K., Whitmore, A. C., Fluet, M. E., Moran, T. P., Shabman, R. S., Collier, M. L., Kraus, A. A., Thompson, J. M., Montefiori, D. C., Beard, C., Johnston, R. E.
(2007). Increased Immunogenicity of a DNA-Launched Venezuelan Equine Encephalitis Virus-Based Replicon DNA Vaccine. J. Virol.
81: 13412-13423
[Abstract]
[Full Text]
-
Zhang, Y., Burke, C. W., Ryman, K. D., Klimstra, W. B.
(2007). Identification and Characterization of Interferon-Induced Proteins That Inhibit Alphavirus Replication. J. Virol.
81: 11246-11255
[Abstract]
[Full Text]
-
Reap, E. A., Dryga, S. A., Morris, J., Rivers, B., Norberg, P. K., Olmsted, R. A., Chulay, J. D.
(2007). Cellular and Humoral Immune Responses to Alphavirus Replicon Vaccines Expressing Cytomegalovirus pp65, IE1, and gB Proteins. CVI
14: 748-755
[Abstract]
[Full Text]
-
Gupta, S., Janani, R., Bin, Q., Luciw, P., Greer, C., Perri, S., Legg, H., Donnelly, J., Barnett, S., O'Hagan, D., Polo, J. M., Vajdy, M.
(2005). Characterization of Human Immunodeficiency Virus Gag-Specific Gamma Interferon-Expressing Cells following Protective Mucosal Immunization with Alphavirus Replicon Particles. J. Virol.
79: 7135-7145
[Abstract]
[Full Text]
-
Gehrke, R., Heinz, F. X., Davis, N. L., Mandl, C. W.
(2005). Heterologous gene expression by infectious and replicon vectors derived from tick-borne encephalitis virus and direct comparison of this flavivirus system with an alphavirus replicon. J. Gen. Virol.
86: 1045-1053
[Abstract]
[Full Text]
-
Song, H. C., Seo, M.-Y., Stadler, K., Yoo, B. J., Choo, Q.-L., Coates, S. R., Uematsu, Y., Harada, T., Greer, C. E., Polo, J. M., Pileri, P., Eickmann, M., Rappuoli, R., Abrignani, S., Houghton, M., Han, J. H.
(2004). Synthesis and Characterization of a Native, Oligomeric Form of Recombinant Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein. J. Virol.
78: 10328-10335
[Abstract]
[Full Text]